title: Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
abstract: Disease trend studies based on birth cohort analysis and serological studies indicate that recent generations have a higher prevalence of oncogenic Human Papilloma Virus (HPV) types, and are likely to be at higher risk of cancer than previous generations. This implies that prevention strategies to protect young populations from HPV-associated cancers need to be strengthened, and hence organized implementation of vaccination and better screening programs are being considered. In this context, randomized large-scale policy evaluations will be instrumental in accelerating disease control and improve effective prevention programs. This report shares experiences from Nordic countries with examples of prevention strategies through vaccination and cervical screening. The same principles as set up for organized programs and new HPV technologies may apply for screening and vaccination as key tools to eliminate cervical cancer in the Nordic countries and globally.
authors.affiliation: WHO Global Reference Laboratory for HPV Diagnosis and Control, Department of Clinical Microbiology, University Hospital, Malmö, Sweden. lena.dillner@med.lu.se
authors.forename: Lena
authors.initials: L
authors.lastname: Dillner
authors.forename: Sonia
authors.initials: S
authors.lastname: Pagliusi
authors.forename: Freddie
authors.initials: F
authors.lastname: Bray
authors.forename: Attila
authors.initials: A
authors.lastname: Lorincz
authors.forename: Susanne K
authors.initials: SK
authors.lastname: Kjaer
authors.forename: Ahti
authors.initials: A
authors.lastname: Anttila
authors.forename: Ole Eric
authors.initials: OE
authors.lastname: Iversen
authors.forename: Joakim
authors.initials: J
authors.lastname: Dillner
authors.forename: Matti
authors.initials: M
authors.lastname: Lehtinen
authors.forename: Jorma
authors.initials: J
authors.lastname: Paavonen
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000276:immunology / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000517:prevention & control* / Q000821:virology*
chemical_list: D053918:Papillomavirus Vaccines